Wang Yi, Huang Chang-Ming, Wang Jia-Bin, Zheng Chao-Hui, Li Ping, Xie Jian-Wei, Lin Jian-Xian, Lu Jun
Department of Gastric Surgery, Fujian Medical University Union Hospital, No, 29 Xinquan Road, Fuzhou 350001, Fujian Province, China.
World J Surg Oncol. 2014 Jan 27;12:21. doi: 10.1186/1477-7819-12-21.
Although cardiac cancer of the remnant stomach and primary cardiac cancer both occur in the same position, their clinical characteristics and outcomes have not been compared previously. The objective of this study was designed to evaluate the prognosis of cardiac cancer of the remnant stomach in comparison with primary cardiac cancer.
In this retrospective comparative study, clinical data and prognosis were compared in 48 patients with cardiac cancer of the remnant stomach and 96 patients with primary cardiac cancer who underwent radical resection from January 1995 to June 2007. Clinicopathologic characteristics, survival times, mortality, and complications were analyzed.
The 5-year survival rate was significantly higher in patients with primary cardiac cancer than in those with cardiac cancer of the remnant stomach (28.4% vs. 16.7%, P = 0.035). Serosal invasion, lymph node metastasis and tumor location were independent prognostic factors for survival. Subgroup analysis, however, showed similar survival rates in patients with primary cardiac cancer and cardiac cancer of the remnant stomach without serosal invasion (25.0% vs. 43.8%, P = 0.214) and without lymph node metastasis (25.0% vs. 38.8%, P = 0.255), as well as similar complication rates (20.8% vs. 11.5%, P = 0.138).
Although the survival rates after radical resection in patients with cardiac cancer of the remnant stomach were poorer than in those with primary cardiac cancer, they were similar in survival rates when patients without serosal invasion or lymph node metastasis. Therefore, early detection is an important way to improve overall survival in cardiac cancer of the remnant stomach.
尽管残胃癌和原发性贲门癌均发生于同一部位,但此前尚未对二者的临床特征及预后进行比较。本研究旨在评估残胃癌与原发性贲门癌的预后情况。
在这项回顾性比较研究中,对1995年1月至2007年6月期间接受根治性切除术的48例残胃癌患者和96例原发性贲门癌患者的临床资料及预后进行了比较。分析了临床病理特征、生存时间、死亡率及并发症情况。
原发性贲门癌患者的5年生存率显著高于残胃癌患者(28.4%对16.7%,P = 0.035)。浆膜侵犯、淋巴结转移及肿瘤位置是生存的独立预后因素。然而,亚组分析显示,无浆膜侵犯的原发性贲门癌患者和残胃癌患者的生存率相似(25.0%对43.8%,P = 0.214),无淋巴结转移的患者生存率也相似(25.0%对38.8%,P = 0.255),并发症发生率同样相似(20.8%对11.5%,P = 0.138)。
尽管残胃癌患者根治性切除术后的生存率低于原发性贲门癌患者,但无浆膜侵犯或淋巴结转移的患者生存率相似。因此,早期发现是提高残胃癌总体生存率的重要途径。